Exchange: NASDAQ·Updated 12:22 PM EDT
NGEN logo

NGENNervGen Pharma Corp

$2.01
$0.05
(2.55%)
Today
EarningsAug 25
Mkt Cap$161.1M
Vol310,222.00
News
all
press releases
News Placeholder
Why Is NervGen Pharma Stock Gaining Tuesday?
NGEN stock climbs as NervGen Pharma NVG-291 hits a 100% responder rate in spinal cord injury gait analysis. Phase 3 set for mid-2026.read more...
Benzinga
News Placeholder
NervGen Pharma Appoints Adam Rogers As CEO
(RTTNews) - NervGen Pharma Corp. (NGEN), Monday announced the appointment of Adam Rogers as President and Chief Executive Officer of the company, effective immediately...
Nasdaq News: Markets
<
...
1
>

Advertisement|Remove ads.